Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363426 · ClinicalTrials.gov registry record · Phase 3
Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation
A Phase 3 study of Infertility, sponsored by Invaron Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02363426: Completed Phase 3 study of Infertility, sponsored by Invaron Pharmaceuticals.
NCT02363426 is a Phase 3 study of Infertility that has completed, run by Invaron Pharmaceuticals. The registered enrollment target is 40 participants, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02363426, a Phase 3 study of Infertility, has completed, sponsored by Invaron Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate intravaginal culture using the medical device INVOcell to generate day 5 blastocysts in comparison to traditional IVF.
Primary Outcome
Blastocyst generation rate: number of day 5 embryos of "good quality" defined as 2BB or greater (expansion of embryo 2,3,4,5 or 6 and inner cell mass and outer cell mass grades of A or B) or higher using the Gardner Grading System divided by the number of eggs incubated
Conditions Studied
Interventions
- DEVICE INVOcell Culture Device
- DEVICE IVF Incubation
Study Locations (1)
Texas
- C.A.R.E. - Beford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-01 |
| Phase | Phase 3 |
What the finished NCT02363426 record still lists
NCT02363426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which INVOcell Culture Device is the first listed.
NCT02363426 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02363426 about?
NCT02363426 is a clinical study titled "Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation". The purpose of this study is to evaluate intravaginal culture using the medical device INVOcell to generate day 5 blastocysts in comparison to traditional IVF.
What is the current status of trial NCT02363426?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2013-01. Estimated completion is 2016-01.
What conditions does trial NCT02363426 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT02363426?
The interventions under investigation include: INVOcell Culture Device (DEVICE), IVF Incubation (DEVICE).
Who is sponsoring clinical trial NCT02363426?
This trial is sponsored by Invaron Pharmaceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02363426 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02363426's enrollment target sits among peer trials
40 65th of 74 higher than 8 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
RECRUITING · Phase 3
-
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
RECRUITING · Phase 3
-
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
COMPLETED · Phase 3
-
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
COMPLETED · Phase 3
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia